Ausgabe 5/2021
Inhalt (27 Artikel)
Up Front
Referees 2020
The discovery of insulin in Toronto: beginning a 100 year journey of research and clinical achievement
Michael Fralick, Bernard Zinman
A global perspective on the issue of access to insulin
David Beran, Maria Lazo-Porras, Camille M. Mba, Jean Claude Mbanya
Consequences of recurrent hypoglycaemia on brain function in diabetes
Rory J. McCrimmon
Defining the underlying defect in insulin action in type 2 diabetes
Thiago M. Batista, Nida Haider, C. Ronald Kahn
‘Smart’ insulin-delivery technologies and intrinsic glucose-responsive insulin analogues
Mark A. Jarosinski, Balamurugan Dhayalan, Nischay Rege, Deepak Chatterjee, Michael A. Weiss
Current and future therapies for type 1 diabetes
Bernt Johan von Scholten, Frederik F. Kreiner, Stephen C. L. Gough, Matthias von Herrath
Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study
Linong Ji, Ying Du, Min Xu, Xiangjun Zhou, Zhaohui Mo, Jianhua Ma, Jiarui Li, Yufeng Li, Jingna Lin, Yanjun Wang, Jing Yang, Weihong Song, Hui Jin, Shuguang Pang, Hui Liu, Ping Li, Jie Liu, Minxiu Yao, Wenhui Li, Xiaohong Jiang, Feixia Shen, Houfa Geng, Haifeng Zhou, Jianmin Ran, Minxiang Lei, Yinghong Du, Shandong Ye, Qingbo Guan, Wenshan Lv, Huiwen Tan, Tao Chen, Jinkui Yang, Guijun Qin, Shiyun Li, Lei Chen
Oral insulin immunotherapy in children at risk for type 1 diabetes in a randomised controlled trial
Robin Assfalg, Jan Knoop, Kristi L. Hoffman, Markus Pfirrmann, Jose Maria Zapardiel-Gonzalo, Anna Hofelich, Anne Eugster, Marc Weigelt, Claudia Matzke, Julia Reinhardt, Yannick Fuchs, Melanie Bunk, Andreas Weiss, Markus Hippich, Kathrin Halfter, Stefanie M. Hauck, Jörg Hasford, Joseph F. Petrosino, Peter Achenbach, Ezio Bonifacio, Anette-Gabriele Ziegler
Potential diabetes overtreatment and risk of adverse events among older adults in Ontario: a population-based study
Iliana C. Lega, Michael A. Campitelli, Peter C. Austin, Yingbo Na, Afshan Zahedi, Freda Leung, Catherine Yu, Susan E. Bronskill, Paula A. Rochon, Lorraine L. Lipscombe
Retinal venular tortuosity and fractal dimension predict incident retinopathy in adults with type 2 diabetes: the Edinburgh Type 2 Diabetes Study
Rachel B. Forster, Emmanuel Sandoval Garcia, Anniek J. Sluiman, Sheila M. Grecian, Stela McLachlan, Tom J. MacGillivray, Mark W. J. Strachan, Jackie F. Price
Size for gestational age affects the risk for type 1 diabetes in children and adolescents: a Swedish national case–control study
Nina Lindell, Marie Bladh, Annelie Carlsson, Ann Josefsson, Karin Aakesson, Ulf Samuelsson
Association of infant diet with subsequent obesity at 2–5 years among children exposed to gestational diabetes: the SWIFT study
Sarvenaz Vandyousefi, Jaimie N. Davis, Erica P. Gunderson
Biphasic dynamics of beta cell mass in a mouse model of congenital hyperinsulinism: implications for type 2 diabetes
Sharona Tornovsky-Babeay, Noa Weinberg-Corem, Rachel Ben-Haroush Schyr, Dana Avrahami, Judith Lavi, Eseye Feleke, Klaus H. Kaestner, Yuval Dor, Benjamin Glaser
Saturated fatty acids entrap PDX1 in stress granules and impede islet beta cell function
Mu Zhang, Chunjie Yang, Meng Zhu, Li Qian, Yan Luo, Huimin Cheng, Rong Geng, Xiaojun Xu, Cheng Qian, Yu Liu
Heterogeneity in insulin-stimulated glucose uptake among different muscle groups in healthy lean people and people with obesity
Han-Chow E. Koh, Stephan van Vliet, Gretchen A. Meyer, Richard Laforest, Robert J. Gropler, Samuel Klein, Bettina Mittendorfer
Genetic ablation of C-reactive protein gene confers resistance to obesity and insulin resistance in rats
Mengliu Yang, Sheng Qiu, Yirui He, Ling Li, Tong Wu, Ning Ding, Fanghong Li, Allan Z. Zhao, Gangyi Yang
The disproportionate excess mortality risk of COVID-19 in younger people with diabetes warrants vaccination prioritisation
Andrew P. McGovern, Nick J. Thomas, Sebastian J. Vollmer, Andrew T. Hattersley, Bilal A. Mateen, John M. Dennis